Andrew Plump
President, Research & Development @ Takeda
Boston, United States
Andrew Plump is a corporate round investor at Takeda in Boston focused on Health Care and Biotechnology. Bachelor's degree, MIT; MD, University of California, San Francisco; PhD, Rockefeller University. Formerly: Senior Vice-President, Research & Translational Medicine, Deputy to the President of R&D, Sanofi; Vice-President, Worldwide Cardiovascular Research Head, Merck. Chief Medical and Scientific Officer and R&D Head, Takeda,leading drug discovery and development across Takeda’s core therapeutic areas, which include oncology, gastroenterology, CNS, cardiometabolic and vaccines.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Andrew Plump invests in
Stages Andrew Plump invests in
Countries Andrew Plump invests in
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Product Research 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Scohia Pharma
|
Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic. | $1.4B / Corporate Round / Mar 14, 2017 |
Co-Investors
About Takeda
Takeda researches, develops, manufactures, sells, markets, imports, and exports pharmaceutical drugs. They offer pharmaceuticals, therapeutics, oncology, and gastroenterology vaccines.
Takeda Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Andrew Plump
President, Research & Development
|
|||
Bin Li
Director of Computational Biology, Takeda Data Science Institute
|
|||
|
Ceri Davies
Head of CNS Drug Discovery Unit
|
|||
Christopher Barr
Takeda Community Engagement
|
|||
Masaru Otsuka
Head of Digital Acceleration
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Andrew Plump invest in?
Andrew Plump invests primarily in Health Care, Biotechnology and Product Research startups, most often at Corporate Round stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Andrew Plump last invest?
The most recent investment recorded for Andrew Plump closed in Mar 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
